Phibro Animal Health Corp
General ticker "PAHC" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $935.3M
Phibro Animal Health Corp follows the US Stock Market performance with the rate: 63.6%.
Estimated limits based on current volatility of 2.4%: low 21.10$, high 22.14$
Factors to consider:
- Company pays dividends: last record date 2024-11-27, amount 0.12$ (Y2.22%)
- US accounted for 59.2% of revenue in the fiscal year ended 2023-06-30
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [14.46$, 22.95$]
- 2025-06-30 to 2026-06-30 estimated range: [16.37$, 25.37$]
Financial Metrics affecting the PAHC estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.19
- Negative: Industry operating cash flow per share per price (median), % of -4.88 <= 3.85
- Negative: Industry inventory ratio change (median), % of 6.44 > 0.49
- Positive: 1.03 < Operating profit margin, % of 5.24
- Negative: Inventory ratio change, % of 2.17 > 1.08
- Negative: Industry earnings per price (median), % of -6.42 <= 1.31
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 0.25
- Negative: 0.14 < Interest expense per share, $ of 0.54
- Positive: -3.48 < Investing cash flow per share, $ of -1.19
- Negative: Operating cash flow per share per price, % of 12.36 <= 12.76
Short-term PAHC quotes
Long-term PAHC plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $942.26MM | $977.89MM | $1,017.68MM |
| Operating Expenses | $863.27MM | $906.04MM | $964.36MM |
| Operating Income | $78.99MM | $71.85MM | $53.31MM |
| Non-Operating Income | $-6.66MM | $-17.78MM | $-42.40MM |
| Interest Expense | $11.90MM | $17.95MM | $21.97MM |
| R&D Expense | $20.83MM | $24.39MM | $29.19MM |
| Income(Loss) | $72.33MM | $54.07MM | $10.92MM |
| Taxes | $23.15MM | $21.46MM | $8.50MM |
| Profit(Loss) | $49.17MM | $32.61MM | $2.42MM |
| Stockholders Equity | $262.44MM | $282.51MM | $256.64MM |
| Inventory | $259.16MM | $277.57MM | $265.91MM |
| Assets | $931.70MM | $971.40MM | $982.18MM |
| Operating Cash Flow | $31.65MM | $13.31MM | $87.59MM |
| Capital expenditure | $37.04MM | $51.79MM | $41.24MM |
| Investing Cash Flow | $-22.58MM | $-74.02MM | $-48.19MM |
| Financing Cash Flow | $16.34MM | $26.99MM | $-6.77MM |
| Earnings Per Share* | $1.21 | $0.81 | $0.06 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.